The Anti-CD27 Varlilumab Biosimilar Monoclonal Antibody (HDBS0018) is a cutting-edge tool designed for research in the field of immunotherapy. This antibody, engineered in a biosimilar format, targets the CD27 protein, a key player in T-cell activation and immune response regulation.Through its high specificity and affinity for CD27, this monoclonal antibody allows for accurate detection and analysis of CD27 expression in various cellular contexts. Its unique design and validation for use in assays such as flow cytometry and immunohistochemistry make it an indispensable tool for researchers studying cancer immunotherapy and autoimmune diseases.
The CD27 protein, also known as Tumor Necrosis Factor Receptor Superfamily Member 7 (TNFRSF7), has emerged as a promising target for immunotherapy in cancer treatment. By understanding the role of CD27 in T-cell activation and immune response modulation, researchers can uncover new insights that may lead to the development of innovative therapeutic strategies for enhancing anti-tumor immunity.With its superior performance and reliability, the Anti-CD27 Varlilumab Biosimilar Monoclonal Antibody (HDBS0018) is a valuable asset for advancing research in the exciting field of cancer immunotherapy.
Product Name:
Varlilumab (Anti-CD27) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0018
Target:
CD27
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
1F5, CDX-1127
Description:
Anti-CD27 (varlilumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
